Ascenta Capital
Overview
Ascenta Capital is a venture capital firm founded in 2023 that is focused on making concentrated investments in biotech companies. The firm partners with companies that have development candidates to help translate their preclinical science into early human safety and efficacy data, with a belief in the opportunity of multi-product platforms. It was co-founded by Dr. Evan Rachlin, formerly of Blackstone Life Sciences, and Dr. Lorence Kim, former CFO of Moderna.
Portfolio Companies
11
Website
ascentacap.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Odyssey Therapeutics | Dec 2023 | Series C | Lead |
| TriveniBio | Jun 2026 | Series C | Lead |
| TRIANA Biomedicines | Dec 2025 | Series B | Lead |
| Alpha-9 Oncology | Oct 2024 | Series C | Lead |
| OrsoBio | Sep 2024 | Series B | Lead |
For institutional investors. Book with your work email.
Key People
Lorence Kim
Co-founder and Advisory Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Ascenta Capital based?
Ascenta Capital is headquartered in New York City, New York, United States.
When was Ascenta Capital founded?
Founding year information for Ascenta Capital is not publicly available.
How many portfolio companies does Ascenta Capital have?
Ascenta Capital has 11 portfolio companies in Caplight's dataset.
What are some companies in Ascenta Capital's portfolio?
Portfolio companies visible on Caplight include Odyssey Therapeutics, TriveniBio, TRIANA Biomedicines, Alpha-9 Oncology, OrsoBio.
What was Ascenta Capital's most recent investment shown here?
Ascenta Capital's most recent investment in this portfolio sample was in TriveniBio in 2026.
What sectors does Ascenta Capital focus on?
Ascenta Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure.
What company stages does Ascenta Capital focus on?
Ascenta Capital typically invests at the Mid stage.
What is Ascenta Capital's AUM?
Ascenta Capital's assets under management are estimated between $237.9M and $350.0M.